The PRINCIPLE randomised controlled open label platform trial of hydroxychloroquine for treating COVID19 in community based patients at high risk (Scientific Reports, 2025)

(untitled) - Hobbs, FDR; Dorward, J; Hayward, G; Yu, L; Saville, BR; Butler, CC